申请人:Wakamoto Pharmaceutical Co., Ltd.
公开号:EP0495526A1
公开(公告)日:1992-07-22
A tetrazoleacetic acid derivative represented by the following general formula (I):
[in Formula (I), R₁ represents a hydrogen atom or a lower alkyl group; R₂, R₃ and R₄ are the same or different from each other and are selected from the group consisting of hydrogen, lower alkyl, halogen, lower haloalkyl, hydroxy and lower alkoxy; and tetrazol group is located at the 1- or 2-position of the naphthyl group] except for [5-(1-naphthyl)tetrazol-1-yl]acetic acid and the ethyl ester thereof; or a salt thereof.
由以下通式(I)代表的四唑乙酸衍生物: [在式 (I) 中,R₁ 代表氢原子或低级烷基;R₂、R₃ 和 R₄ 彼此相同或不同,并且选自由氢、低级烷基、卤素、低级卤代烷基、羟基和低级烷氧基组成的组; 且四唑基位于萘基的 1 位或 2 位],但[5-(1-萘基)四唑-1-基]乙酸及其乙酯或其盐除外。